| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a7ac31dafa9b644bcbf73f79c4695dc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-00 |
| filingDate |
2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa4ee720e7268cb9bc5e7b79949ec654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e84d131de3c5c76a195898ee7e035944
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_829f424ffa02dc1eee2e4dbb1168b6b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f804e8ee1d2ebed25cb8eaecb2c89a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61ebcaab6f43c1fd0405d8d346f33ee1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b41ba7a386d55132e4712e75b4bd1cb |
| publicationDate |
2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020139916-A1 |
| titleOfInvention |
Inhibiting ubiquitin specific peptidase 9x |
| abstract |
The disclosure provides novel chemical compounds useful as inhibitors of ubiquitin specific peptidase 9X (USP9X). USP9X inhibiting compounds are useful in the treatment of disease and disorders associated with modulation of USP9X, such as cancer. |
| priorityDate |
2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |